COVID-19: How Pfizer is responding
Could better communication improve adherence to medicines after patients leave hospital?
Reducing blood pressure can take years off your ‘Heart Age’
New model for managing pain could ease the burden on patients and health systems
Older people & polypharmacy: getting their medication right
How taking your medicines can impact quality of life
Project chAnGE: accelerating changes in clinical practice to combat NCDs and support healthy ageing
Unlocking the potential of cancer data: Announcing the Oncology Data Summit
Back to Home
Pfizer in Europe
Improving Access to Medicines
How do we develop medicines?
Antimicrobial Resistance (AMR)
EU research and innovation policy
How does Pharmaceutical IP work?
EU Trade Policy
Follow us on twitter